Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-24

Clinical Trial Update: Lidocaine Combined With Sufentanil for Preventing Catheter-related Bladder Discomfort [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating lidocaine combined with sufentanil to prevent catheter-related bladder discomfort in patients with prostate cancer; status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lidocaine (Lidocaine)
  • Sufentanil (sufentanil)

Snippet

Sponsor: RenJi Hospital | Conditions: Prostate Cancer | Phase 4 | Status: UNKNOWN